Targeting non-coding RNAs for the treatment of retinal diseases
Maintaining visual function is key to establishing improved longevity. However, the numbers of patients with diseases of the retina, the most important tissue for vision and the key to age-related blindness, are not declining due to the increase in the number of aging subjects worldwide and the tech...
Main Authors: | Juhyun Song, Young-Kook Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253121000664 |
Similar Items
-
Research progress of LncRNA in retinal pigment epithelium associated retinal diseases
by: Zi-Yan Tang, et al.
Published: (2019-08-01) -
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases
by: Xiaozheng Dou, et al.
Published: (2020-12-01) -
ATP and Adenosine in the Retina and Retinal Diseases
by: Shan-Shan Ye, et al.
Published: (2021-06-01) -
New insight into the role of the complement in the most common types of retinopathy-current literature review
by: Martyna Chrzanowska, et al.
Published: (2018-11-01) -
Research progress of circular RNAs in ocular proliferative diseases
by: Tian-Jing Yang, et al.
Published: (2021-06-01)